期刊文献+

人乳头瘤病毒16型E7基因原核表达载体的构建及表达

Construction and expression of human papillomavirus type-16 E7 gene in prokaryotic expressing vector
下载PDF
导出
摘要 目的:构建人乳头瘤病毒16型(HPV-16)E7基因原核表达载体,观察目的基因的蛋白表达。方法:人工合成HPV16E7基因核苷酸序列,利用特异性引物通过聚合酶链反应扩增HPV16E7基因,并克隆至pGEX-4T1原核表达载体,构建重组表达载体pGEX-4T1-HPV16-E7。将其转化到工程菌Rosetta后,经IPTG诱导表达,进行E7-GST融合蛋白的SDS-PAGE分析和Ni 2+-NTA亲和层析纯化。结果:E7基因PCR扩增产物和重组表达质粒的双酶切产物经琼脂糖凝胶电泳,均可见300bp的目的基因条带。表达的重组蛋白经SDS-PAGE电泳和纯化后,在相对分子质量约36 000处有特异性表达带,与预期相符。结论:在原核系统中含E7基因的重组质粒可有效表达E7-GST融合蛋白。 Objective To construct prokaryotic expression vector harboring human papillomavirus-16 E7(HPV-16) gene and observe the E7 protein expression.Methods Synthetic E7 gene was amplified using polymerase chain reaction and subcloned into prokaryotic expressing vector pGEX-4T1.The recombinant plasmids,pGEX-4T1-HPV16-E7,were transferred into engineering bacteria Rosetta,and the fusion proteins E7-GST were analyzed on SDS-PAGE and purified by Ni2^+-NTA affinity chromatography under induction with IPTG.Results The target gene fragment at a length of 300 bp was observed on the agarose gel electrophoresis pattern and PCR.SDS-PAGE analysis showed that the expressed recombinant protein,with a relative molecular mass of about 36 000,could be found.Conclusion The recombinant protein,E7-GST,is effectively expressed in prokaryotic expression system.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2011年第4期661-664,共4页 Journal of Jilin University:Medicine Edition
基金 吉林省卫生厅重点实验室项目资助课题(2008Z015)
关键词 人乳头瘤病毒16型 聚合酶链式反应 原核表达载体 human papillomavirus 16 polymerase chain reaction prokaryotic expression vector
  • 相关文献

参考文献2

二级参考文献20

  • 1DIRK K, CHRISTOPH L, ANDREA K, et al. Efficiency of HPV 16 L1E7 DNA immunization influence of cellular localization and capsid assembly[J]. Vaccine, 2006, 15 (15): 2952-2965.
  • 2MARCI O, LASARO D, MARIANA O, et al. Anti-tumor DNA vaccines based on the expression of human papillomavirus16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1 microbes and infection[J]. Microbes and Infection, 2005, 7 (15) : 1541 - 1550.
  • 3MONA S, MARC T, GOODMAN S, et al. Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines : the potential role [ J ]. Cancer Supplement, 2008, 113(10) : 3047 -3057.
  • 4DAEJIN K, RATISH G, BALASUBRAMANYAM K, et al. Generation and characterization of a preventive and therapeutic HPV DNA vaccine [ J ]. Vaccine, 2008, 26 (3) : 351 -360.
  • 5WOLFRAM O, TANJA P, SANDRA C, et al. A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16 ) induces E7-specific cytotoxic T ceils but lacks transforming activity [ J ]. Vaccine, 2001, 19(30) : 4276 -4286.
  • 6Crook T, Morgenstern JP, Crawford LL, et al. Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-tranformed by HPV-16 plus EJ-ras [J]. EMBO J, 1989, 8(2): 513-519.
  • 7Muderspach L, Wilczynski S, Riman L, et al. A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical cancer and vular intraepicelial neollasia who are HPV 16 positive [J]. Clin Canecer Res, 2000, 6(9): 3406-3416.
  • 8Zhou XS, Qian XL, Zhao QZ, et al. Efficient expression of modified human papillomavirus 16 E6/E7 fusion protein and the anti-tumor efficacy in a mouse model [J]. Biol Pharm Bull, 2004, 27(3): 303-307.
  • 9Lin KY, Guarnieri FG, Stavelev-O'Canrroll KF, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class Ⅱ presentation of tumor antigen [J]. Cancer Res, 1996, 56(1): 21-26.
  • 10Graf MR, Prins RM, Hawkins WT, et al. Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination [J]. Cancer Immunol Immunother, 2002, 51(4): 179-189.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部